REGN
NASDAQ HealthcareRegeneron Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $746.61 |
|---|---|
| Volume | 630,243 |
| Market Cap | 78.93B |
| Dividend Yield | 0.49% |
| Beta | 0.400 |
| RSI (14-Day) | 41.8 |
| 200-Day MA | $644.36 |
| 50-Day MA | $769.88 |
| 52-Week High | $821.11 |
| 52-Week Low | $476.49 |
| P/E Ratio | 18.02 |
| Forward P/E | 14.14 |
| Price / Book | 2.45 |
🎯 Investment Strategy Scores
How REGN scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
54/100
High dividend yield + low volatility
🚀 Moon Shot
22/100
High growth potential (high beta + oversold)
🔪 Falling Knife
28/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
57/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
94/100
Large-cap, institutional-quality stocks
Find REGN in your text
Paste any text on the homepage — the tool will extract REGN and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.